Skip to content

NATRELLE Silicone-Filled Breast Implants 115-586Recalls & reported problems

Allergan, Inc. · NATRELLE St 115-586 Moderate plus profile BIOCELL |textured|round|silicone · Class 3 · Implant

All models of Natrelle Breast Implants (1167) · NATRELLE Silicone-Filled Breast Implants (128)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

1 open recall names this device. See the recall details and contact the manufacturer or your healthcare provider.

Adverse event reports
4
Deaths reported
0
Injuries reported
4
Recalls naming it
1

Summary

The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 10888628002463), received between May 6, 2022 and Sep 14, 2026 — classified as 4 injuries.

The most frequently reported specific device problem is “Material Rupture” (3 reports).

1 FDA recall record name this device's identifier, 1 still open.

3 other recalls cover devices cleared under the same FDA submission (P020056); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 1 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 1 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 1 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Recalls naming this device

  1. Jul 24, 2019Class IOpen, Classified

    The action was initiated following notification by the U.S. FDA of their recently updated, global safety information concerning the higher incidence of anaplastic large cell lymphoma (BIA-ALCL) in patients who have textured breast implants.

    Z-2454-2019 · Root cause: Unknown/Undetermined by firm · Recall details · FDA record ↗

Most reported problems

Device problems

  • Material Rupture3
  • Device Appears to Trigger Rejection2

Patient problems

  • Capsular Contracture2
  • Malaise1
  • No Clinical Signs, Symptoms or Conditions1
  • Seroma1

Recent adverse event reports

The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.

  • InjurySep 14, 2026Material Rupture

    Healthcare professional reported "Rupture" and "exchange from textured to a smooth". This record is for the right side. Device was explanted and replaced.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50752884 ↗
  • InjuryApr 6, 2026Material Rupture

    PATIENT REPORTED "RUPTURE" "EXCHANGE DUE TO CONCERN WITH THE PRODUCT". PATIENT ADDITIONALLY REPORTED "GENERALLY FEELING UNWELL"; THIS EVENT IS NOT RELATED TO THE DEVICE. PATIENT REPRESENTATIVE REPORTED "PLAINTIFF WAS IMPLANTED WITH BIOCELL DEVICES, WHICH PLAINTIFF CONTENDS CAUSED INJURIES. MANUFACTURING DEFECT, FAILURE TO WARN, BREACH OF EXPRESS WARRANTY, NEGLIGENCE, AND CONSUMER FRAUD. PATIENT HAS NOT BEEN DIAGNOSED WITH BIA-ALCL". THIS RECORD IS FOR THE LEFT SIDE. DEVICE WAS EXPLANTED.

    Patient problems: Malaise

    MAUDE report 24795471 ↗
  • InjuryAug 12, 2025Device Appears to Trigger Rejection; Material Rupture; Device Appears to Trigger Rejection; Material Rupture

    HEALTHCARE PROFESSIONAL REPORTED "TEXTURED IMPLANTS". THIS RECORD IS FOR THE RIGHT SIDE. DEVICE REMAINS IMPLANTED. HEALTHCARE PROFESSIONAL LATER REPORTED "CAPSULAR CONTRACTURE BAKER GRADE IV", "RUPTURE" AND "FLUID ACCUMULATION".

    Patient problems: Capsular Contracture; Seroma

    MAUDE report 22786519 ↗
  • InjuryMay 6, 2022Device Appears to Trigger Rejection; Device Appears to Trigger Rejection

    PATIENT REPRESENTATIVE REPORTED "LEFT CAPSULAR CONTRACTURE REQUIRING BILATERAL CAPSULOTOMIES AND INCREASED RISK OF ALCL. PATIENT HAS NOT BEEN DIAGNOSED WITH BIA-ALCL." THIS RECORD IS FOR THE LEFT SIDE. THE DEVICE REMAINS IMPLANTED.

    Patient problems: Capsular Contracture

    MAUDE report 14309492 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under P020056. One submission often covers many models, so check the product and lot details in each record.

  • Z-0701-2020 · Nov 6, 2019 · Terminated
    Natrelle Inspira Sillicone-Filled Breast Implants for the following Styles and Sizes: 7607 SSM, 7608 SSF, 7609 SSX, 7513 SRL, 7514 SRLP, 7515 SRM, 7516 SRF, 7517 SRX, 7626 SCL, 762
  • Z-0700-2020 · Nov 6, 2019 · Terminated
    Natrelle Silicone Filled Breast Implants for the following Styles and Sizes: Style 10, Style 15, Style 20, Style 40, Style 45 Style 10/UDI: NATRELLE Style 10-180 Gel Round Mod
  • Z-2453-2019 · Jul 24, 2019 · Open, Classified
    Natrelle Inspira, Silicone-Filled Breast Implants, Sterile, for the following style numbers: Style TRL: TRL-110TRL-125,TRL-140,TRL-170,TRL-200,TRL-230,TRL-260,TRL-290,TRL-320,TR

Other Prosthesis, Breast, Noninflatable, Internal, Silicone Gel-Filled devices

All Prosthesis, Breast, Noninflatable, Internal, Silicone Gel-Filled devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page